Monday, 21 September 2020


CSL makes a settlement in Perth vaccine victim case

09 June 2014 | News | By BioSpectrum Bureau

Ms Button will receive a million dollar settlement from CSL following disability due to vaccination

Ms Button will receive a million dollar settlement from CSL following disability due to vaccination

Singapore: In an ongoing case where Perth-based Ms Saba Button suffered severe disability following a flu vaccine manufactured by Australia's leading biotech firm CSL, the Australian Court finally announced a settlement for the victim.

Ms Saba Button, who was severely disabled after receiving a flu vaccination received a multi-million dollar compensation to meet her lifelong needs, as declared by the federal court justice, Mr Michael Barker.

Ms Saba Button is said to have suffered severe brain and organ damage after getting the 0.25 ml of Fluvax shot when she was 11 months old in 2010. She sustained hypoxic brain injury and severe disabilities, following the vaccination. Her parents had then sough legal recourse in the Federal Court against the vaccine's manufacturer, CSL claiming substantial compensation for the loss and damage she suffered, as a result of receiving the vaccination.

Mr Justice Barker said, "Her life expectancy had been significantly shortened, and disabilities were profound and permanent."

The company had filed a defence denying any liability to Ms Saba, claiming that the State's health ministry was responsible for any compensation due. For this the State's health ministry had filed a cross claim, denying any liability in the matter.

Ms Saba's father, Mr Mick Button, said that it was a long battle and that they can now provide their child with the care, therapy and equipment needed for leading a good life.

 


Sign up for the editor pick and get articles like this delivered right to your inbox.

Editors Pick
+Country Code-Phone Number(xxx-xxxxxxx)


Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account




Podcast

 

Survey Box

Should we be cautious of viewing COVID-19 vaccine as silver bullet?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls